Sangamo Biosciences, Inc.

NASDAQ: SGMO
$11.42
-$0.02 (-0.2%)
Real time price as of May 28, 2020 3:47 pm EDT
Many of the larger biotechnology and pharmaceutical companies have changed strategies from making acquisitions of speculative biotech outfits. In many cases it is far cheaper to just partner up with...
Jon C. Ogg
Sangamo Therapeutics made a handy gain to start out the week after the firm, in conjunction with Pfizer, announced updated results from a mid-stage trial evaluating a treatment for hemophilia.
Chris Lange
Sangamo Therapeutics shares jumped on Tuesday after the company announced interim data from its midstage hemophilia trial in collaboration with Pfizer.
Chris Lange
Gene therapy may become the next frontier for drug companies seeking to make billions of dollars improving or even curing certain diseases.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amarin, Apple, AutoNation, BlackRock, E*Trade, Etsy, Kellogg and PG&E.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Friday included ArcelorMittal, Barclays, Cree, Ctrip.com, Michael Kors, PVH, Skyworks Solutions, TripAdvisor, YRC Worldwide and Yelp.
Jon C. Ogg
If the collaboration between Sangamo and Kite Pharma works out, some investors might just ask why Gilead did not just acquire Sangamo.
Jon C. Ogg
Sangamo Therapeutics saw its shares make a solid gain on Thursday after the company announced that it had entered into a worldwide partnership with a subsidiary of Gilead Sciences.
Chris Lange
Sangamo Therapeutics shares made a handy gain on hump day after the firm announced that it would be collaborating with pharma giant Pfizer.
Chris Lange
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
Chris Lange
While some of the price targets discussed here call for a stock to double, or even to rise exponentially, it is important to understand that there is a much larger risk when an analyst calls for such...
Chris Lange
Jefferies has picked out a few companies in the biotech industry that stand to win big over the coming year.
Chris Lange
Here are seven speculative biotech and biohealth stocks where analysts gave huge upside calls during the month of May 2017.
Jon C. Ogg
Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.
Chris Lange
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Baker Hughes, Brocade Communications, CenturyLink, Chevron, Juniper Networks and National Oilwell Varco.
Jon C. Ogg